Mechanisms of status epilepticus: An evidence-based review

Current Opinion in Neurology

Volumn 20, Issue 2, 2007, Pages 213-216

  Murdoch, David ^a,b  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b WOLTERS KLUWER HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; DYNORPHIN; FOSPHENYTOIN SODIUM; GALANIN; HISTAMINE H3 RECEPTOR AGONIST; KAINIC ACID; LIPID; LITHIUM; LORAZEPAM; MIDAZOLAM; NEUROKININ B; NITRITE; PENTETRAZOLE; PHENOBARBITAL; PILOCARPINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SUBSTANCE P; VALPROIC ACID;

BENIGN CHILDHOOD EPILEPSY; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; EPILEPTIC STATE; EPILEPTOGENESIS; EXPERIMENTAL MODEL; GRAND MAL EPILEPSY; HUMAN; LIPID PEROXIDATION; META ANALYSIS; PATHOPHYSIOLOGY; RECEPTOR DENSITY; RECEPTOR UPREGULATION; REVIEW; SYSTEMATIC REVIEW;

EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; STATUS EPILEPTICUS;

EID: 33947176998     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000263155.48598.41     Document Type: Review

References (41)

1. Sirven JI, Waterhouse E. Management of status epilepticus. Am Fam Physician 2003; 68:469-476.
2. Noe KH, Manno EM. Mechanisms underlying status epilepticus. Drugs Today (Barc) 2005; 41:257-266.
3. Zhang XX, Feng YK. A clinical study of 100 status epilepticus cases. Chin Med J 1982; 95:113-120.
4. Lacroix J, Deal C, Gauthier M, et al. Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience. Crit Care Med 1994; 22:827-832.
5. Dunn DW. Status epilepticus in children: etiology, clinical features, and outcome. J Child Neurol 1988; 3:167-173.
6. Martin ED, Cena V, Pozo MA. Cholinergic modulation of status epilepticus in the rat barrel field region of primary somatosensory cortex. Exp Neurol 2005; 196:120-125.
7. Bleck TP. Refractory status epilepticus. Curr Opin Crit Care 2005; 11:117-120.
8. Treiman DM. Therapy of status epilepticus in adults and children. Curr Opin Neurol 2001; 14:203-210.
9. Singleton MW, Holbert IW, Ryan ML, et al. Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat. Brain Res Dev Brain Res 2005; 156:67-77.
10. Freitas RM, Bezerra Felipe CF, Nascimento VS, et al. Pilocarpine-induced seizures in adult rats: monoamine content and muscarinic and dopaminergic receptor changes in the striatum. Comp Biochem Physiol C Toxicol Pharmacol 2003; 136:103-108.
11. Vianna EPM, Ferreira AT, Dona F, et al. Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia 2005; 46 (Suppl 5):166-173.
12. Singleton MW, Holbert IW, Lee AT, et al. Modulation of CaM kinase II activity is coincident with induction of status epilepticus in the rat pilocarpine model. Epilepsia 2005; 46:1389-1400.
13. Garcia-Cairasco N, Rossetti F, Oliveira JA, Furtado Mde A. Neuroethological study of status epilepticus induced by systemic pilocarpine in Wistar audiogenic rats (WAR strain). Epilepsy Behav 2004; 5:455-463.
14. Bellissimo MI, Amado D, Abdalla DSP, et al. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res 2001; 46:121-128.
15. Freitas RM, Vasconcelos SMM, Souza FCF, et al. Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. FEBS J 2005; 272:1307-1312.
16. Freitas RM, Sousa FCF, Viana GSB, Fonteles MMF. Acetylcholinesterase activities in hippocampus, frontal cortex and striatum of Wistar rats after pilocarpine-induced status epilepticus. Neurosci Lett 2006; 399:76-78.
17. Costa MS, Funke MG, de Meis L, et al. Status epilepticus induced by pilocarpine and Ca2+ transport by microsome in the hippocampus of rats. Neurosci Lett 2004; 366:292-296.
18. Freitas RM, Sousa FC, Vasconcelos SM, et al. Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex. Pharmacol Biochem Behav 2004; 78:327-332.
19. Huang LT, Liou CW, Yang SN, et al. Aminophylline aggravates long-term morphological and cognitive damages in status epilepticus in immature rats. Neurosci Lett 2002; 321:137-140.
20. 14C-zonisamide in rat brain during kainic acid-induced limbic seizures. Can J Neurol Sci 2001; 28:341-345.
21. Mikati MA, Werner S, Shalak L, et al. Stages of status epilepticus in the developing brain. Epilepsy Res 2003; 55:9-19.
22. Ueda Y, Yokoyama H, Nakajima A, et al. Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus. Exp Brain Res 2002; 147:219-226.
23. Liang LP, Patel M, Liang L-P, Patel M. Seizure-induced changes in mitochondrial redox status. Free Radic Biol Med 2006; 40:316-322.
24. Lintunen M, Sallmen T, Karlstedt K, Panula P. Transient changes in the limbic histaminergic system after systemic kainic acid-induced seizures. Neurobiol Dis 2005; 20:155-169.
25. Yamagata Y, Imoto K, Obata K. A mechanism for the inactivation of Ca2+ calmodulin-dependent protein kinase II during prolonged seizure activity and its consequence after the recovery from seizure activity in rats in vivo. Neuroscience 2006; 140:981-992.
26. Kubera M, Budziszewska B, Jaworska-Feil L, et al. Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats. Pol J Pharmacol 2004; 56:553-561.
27. Wasterlain CG, Mazarati AM, Naylor D, et al. Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia 2002; 43 (Suppl 5):20-29.
28. Naylor DE, Wasterlain CG. GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia 2005; 46 (Suppl 5):142-147.
29. Gibbs JE, Walker MC, Cock HR. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 2006; 47:469-478.
30. Mazarati AM, Sofia RD, Wasterlain CG. Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus. Seizure 2002; 11:423-430.
31. Silva-Barrat C, Velluti J, Szente M, et al. Exaggeration of epileptic-like patterns by nicotine receptor activation during the GABA withdrawal syndrome. Brain Res 2005; 1042:133-143.
32. Silva-Barrat C, Szente M, Menini C, et al. Muscarinic depression of synaptic transmission in the epileptogenic GABA withdrawal syndrome focus. J Neurophysiol 2001; 85:2159-2165.
33. Goodkin HP, Yeh JL, Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurosci 2005; 25:5511-5520.
34. Prasad A, Williamson JM, Bertram EH. Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann Neurol 2002; 51:175-181.
35. Giorgi FS, Ferruci M, Lazzeri G, et al. A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus. Eur J Neurosci 2003; 17:2593-2601.
36. Martella G, De Persis C, Bonsi P, et al. Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity. Epilepsia 2005; 46:624-635.
37. Avsar E, Empson RM. Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy. Neuropharmacology 2004; 47:427-437.
38. Wong M, Wozniak DF, Yamada KA. An animal model of generalized nonconvulsive status epilepticus: immediate characteristics and long-term effects. Exp Neurol 2003; 183:87-99.
39. Martin ED, Cena V, Pozo MA. Cholinergic modulation of status epilepticus in the rat barrel field region of primary somatosensory cortex. Exp Neurol 2005; 196:120-125.
40. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005; 20 (Suppl 1):S1-S56.
41. Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol 1999; 14:602-609.